secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K/A
Filed at:   2023-03-31T23:59:59+00:00
Accession:  0001493152-23-010412
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical files audited FY2022 financials; auditor flags going concern with $34K cash vs $12.7M liabilities
--------------------------------------------------------------------------------

- Cash at Dec 31, 2022: $34K; total current liabilities $12.7M; working capital deficit of $10.8M.
- Auditor's report includes going-concern emphasis: substantial doubt about ability to continue.
- Net loss for FY2022 not disclosed in this excerpt, but accumulated deficit and negative equity implied.
- Deferred offering costs of $1.8M suggest ongoing capital-raising efforts.
- Short-term loans of $776K outstanding; accounts payable and accrued expenses $11.4M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223010412/0001493152-23-010412-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000149315223010412/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-010412

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer